Defunct Company
Total Trials
15
As Lead Sponsor
As Collaborator
0
Total Enrollment
9,706
NCT00583297
Genetic Substudy of the Alternans Before Cardioverter Defibrillator (ABCD) Trial
Phase: N/A
Role: Lead Sponsor
Start: Jan 31, 2007
Completion: Dec 31, 2009
NCT00500617
Personalized Risk Evaluation and Diagnosis (Using Corus CAD or ASGES) in the Coronary Tree
Start: Jul 31, 2007
Completion: Sep 30, 2011
NCT00500708
Diagnostic Investigation of Sudden Cardiac Event Risk
Completion: Aug 1, 2011
NCT00507013
Hemostatic Closure of Femoral Artery Access Site, Using the QuickClose
Phase: Phase 1/2
Completion: Sep 30, 2007
NCT01117506
Coronary Obstruction Detection by Molecular Personalized Gene Expression (Corus CAD or ASGES)
Start: Apr 30, 2010
Completion: May 31, 2012
NCT01121510
Hemostatic Closure of Femoral Artery Access Site, Using the QuickClose Design 9 System
Start: May 31, 2010
Completion: May 31, 2011
NCT01251302
Utility of a Molecular Personalized Coronary Gene Expression Test (Corus CAD or ASGES) on Cardiology Practice Pattern
Start: Nov 30, 2010
Completion: Jun 30, 2012
NCT01486030
Effect of Exercise Stress Testing on Peripheral Gene Expression Using Corus CAD (or ASGES) Diagnostic Test
Start: Sep 30, 2011
Completion: Nov 30, 2013
NCT01557855
Investigation of a Novel Gene Expression Test (ASGES or Corus CAD) for Diagnosis of Obstructive Coronary Artery Disease
Start: Apr 30, 2012
Completion: May 31, 2013
NCT01594411
PCP Use of a Gene Expression Test (Corus CAD or ASGES) in Coronary Artery Disease Diagnosis
Completion: Feb 28, 2013
NCT01677156
A Registry to Evaluate Patterns of Care Associated With the Use of Corus CAD (or ASGES) in Primary Care Settings
Start: Aug 31, 2012
Completion: Oct 31, 2015
NCT02223286
Understanding Clinician Utilization of Corus CAD (Age/Sex/Gene Expression Score - ASGES) in Clinical Decision Making
Start: Mar 31, 2013
Completion: Aug 31, 2014
NCT02440893
Understanding the Effect of Metformin on Corus CAD (or ASGES)
Start: Sep 30, 2013
Completion: Jun 30, 2014
NCT02405754
Clinical Utility of an Age, Sex, and Gene Expression Score (ASGES or Corus CAD) in African American Patients.
Start: Feb 28, 2014
NCT02158754
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Start: May 31, 2014
Completion: Jun 30, 2015